Zobrazeno 1 - 10
of 106
pro vyhledávání: '"G. N. Stemmermann"'
Autor:
A M Y Nomura, G N Stemmermann
Publikováno v:
Histopathology. 49:45-51
Aims : A substantial minority of intestinal metaplasia (IM)-associated stomach cancers express a gastric product—pepsinogen group II (PGII). The aim of this study was to examine PGII expression as it relates to IM and to tumour heterogeneity. Metho
Autor:
G. N. Stemmermann, Constantine A. Axiotis, David E. Kleiner, Abraham M. Y. Nomura, Chu Chieh Hsia, Edward Tabor, A. M. Di Bisceglie
Publikováno v:
JNCI Journal of the National Cancer Institute. 84:1638-1641
Background Mutations of the p53 tumor suppressor gene have been reported in 50% of patients with hepatocellular carcinoma (HCC) from China and South Africa. These reports suggested an association of p53 mutations with high levels of aflatoxin in the
Autor:
G. N. Stemmermann
Publikováno v:
Archives of Internal Medicine. 151:969-972
Publikováno v:
Diseases of the Colon & Rectum. 33:190-194
This prospective study assesses the impact of fat and calcium intake on the risk of developing cancer in each large-bowel subsite. The study population is a cohort of Hawaii Japanese men who experience high rates of colon cancer, especially of the si
Autor:
G N, Stemmermann, A M Y, Nomura
Publikováno v:
Histopathology. 49(1)
A substantial minority of intestinal metaplasia (IM)-associated stomach cancers express a gastric product-pepsinogen group II (PGII). The aim of this study was to examine PGII expression as it relates to IM and to tumour heterogeneity.The extent of I
Autor:
P, Correa, G N, Stemmermann
Publikováno v:
Pathologica. 97(5)
Publikováno v:
Comparative medicine. 50(5)
Mice lacking the NHE2 Na+/H+ gene develop gastritis of the glandular mucosa as early as the tenth day of life, achieving maximal intensity of inflammation from 17 to 19 days after birth and maximal atrophy at one year. We assessed the effects of this
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(9)
It is suspected that selenium is protective against prostate cancer. To test this hypothesis, we conducted a nested case-control study in a cohort of 9345 Japanese-American men examined between 1971 and 1977. At the time of examination, a blood speci
Autor:
D, Tolbert, C, Fenoglio-Preiser, A, Noffsinger, G, De Voe, J, MacDonald, J, Benedetti, G N, Stemmermann
Publikováno v:
Cancer causescontrol : CCC. 10(3)
We investigated p53 gene mutations in advanced gastric cancers by direct DNA sequencing, in order to determine the frequency of mutations in gastric cancers having different epidemiological backgrounds, tumors of the cardia were compared with those a